Skip to main content
BIO-FD&C CO.,LTD. logo

BIO-FD&C CO.,LTD. — Investor Relations & Filings

Ticker · 251120 ISIN · KR7251120002 KO Manufacturing
Open in API
Filings indexed 95 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 251120

About BIO-FD&C CO.,LTD.

https://www.biofdnc.com/?lang=en

BIO-FD&C CO.,LTD. is a biotechnology company specializing in research and development based on a proprietary, sustainable plant cell platform technology. The company develops and commercializes high-value active ingredients for the cosmetics, pharmaceutical, and food industries. Its product portfolio includes plant cell-derived materials, bioactive recombinant proteins, growth factors, and peptides, with a significant focus on anti-aging ingredients for cosmeceuticals. Leveraging advanced techniques such as bioreactor cultivation, radiofrequency-enhanced production of bioactive compounds (SMART-RC2), and plant cell cryopreservation, the company is also exploring the development of plant cell-based therapeutics, including antibodies and vaccines.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document header and content identify it as a Korean "분기보고서" (quarterly report) for the company’s 22nd fiscal year 1st quarter (2026/01/01–2026/03/31). It is over 200,000 characters, includes detailed company overview, business descriptions, capital changes, share counts, and will contain actual financial statements further on. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 91% confidence The document is a “주식등의 대량보유상황보고서” (report on large shareholdings) filed under Korea’s Capital Markets Act, detailing a major shareholder’s stock holdings, related party schedules, contractual arrangements, and changes in shareholding. This matches our category for notifications of significant share ownership changes. It is not an earnings release, annual or interim report, management change, or any other type. Therefore it is classified as a Major Shareholding Notification (MRQ).
2026-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and contains detailed voting outcomes for each AGM agenda item (approval of financial statements, amendments to the articles, auditor appointment, remuneration limits, etc.) with vote percentages. This clearly matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (code DVA).
2026-03-30 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 21st fiscal year (2025) of BioFD&C Co., Ltd. It contains detailed company information, management discussion, financial data, and governance details. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K annual report, providing comprehensive yearly financial and operational performance. FY 2025
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 99% confidence The document is a regulatory filing from a Korean company (BioFD&C) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit), and auditor information. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2025
2026-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for BioFD&C. It contains the meeting agenda, details on board activities, and financial statements for the 21st fiscal year. In the context of regulatory filings, this document is a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on agenda items (such as financial statement approval, director appointments, and remuneration limits) at the upcoming meeting.
2026-03-11 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.